The role of Lyt-2 + T cells in the regulation of autoimmunity in murine lupus

Abstract

Systemic lupus erythematosus (SLE) in humans and in mice is characterized by reduced suppressor T-cell activity. This observation suggests that selective loss or impaired function of suppressor T cells may contribute to the development of autoimmunity. To clarify the role of suppressor T cells in the pathogenesis of SLE, we used a rat MAb to selectively deplete Lyt-2 + (‘suppressor/cytotoxic’) T cells from lupus-prone NZB NZW F 1 ( B W ) mice. Treatment consisted of weekly intraperitoneal injections of anti-Lyt-2 (2 mg/mouse) beginning at age 4 months, prior to the onset of overt clinical illness. Control mice received weekly injections of either non-immune rat IgG or saline. Despite sustained depletion of Lyt-2 + T cells, mice treated with anti-Lyt-2 were indistinguishable from control mice with respect to production of anti-DNA antibodies, development of renal disease, and mortality. These findings imply that Lyt-2 + T cells do not regulate autoimmunity in B W mice. However, they do not exclude the possibility that Lyt-2 + T cells suppress autoimmunity in normal mice but are simply non-functional in B W mice. Therefore, we also examined the consequences of depleting Lyt-2 + T cells from non-autoimmune C57BL 6 × NZW ( B6 NZW ) mice. Depletion of Lyt-2 + T cells from B6 NZW from age 4 to 10 months produced neither serologic nor clinical evidence of murine lupus. These observations suggest that suppressor T cell defects are not sufficient to cause murine lupus.